NSE
Poly Medicure LimitedPOLYMED
Poly Medicure Limited is an NSE-listed company (POLYMED).
AI-generated overview β verify before relying on it.
Net institutional flow
ββΉ156.3 Cr
Institutional buyers
0 in / 1 out
High-impact filings
0 Β· tilt Neutral
Next corporate action
Dividend - Rs 3.50 Per Share
ex 2025-09-18
Competitive landscape β the read
vs mapped peers| # | Company | Inst. flow βΉCr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ACUTAAS | +βΉ98.2 Cr | 1 | β | β | +4 | 6 |
| 2 | AAVAS | +βΉ79.7 Cr | 5 | β | β | β | β |
| 3 | AADHARHFC | β | β | β | β | β | β |
| 4 | AARTIIND | +βΉ0 Cr | 4 | β | β | β | β |
| 5 | ACE | +βΉ0 Cr | 2 | β | β | β | β |
| 6 | ACMESOLAR | ββΉ80.9 Cr | 1 | β | β | +3 | 6 |
| 7 | POLYMEDThis | ββΉ156.3 Cr | 3 | β | β | β | β |
| 8 | ABLBL | ββΉ314.4 Cr | 29 | β | β | β | β |
| 9 | ABFRL | ββΉ730.3 Cr | 13 | β | +1 | β | β |
Ranked by net institutional flow (buys β sells, βΉCr). Filing momentum = bullish β bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
Timeline β POLYMED day by day
- 2026-06-15FilingPoly Medicure Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SecuritShareholding Disclosure
- 2026-06-15FilingPoly Medicure Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SecuritShareholding Disclosure
- 2026-06-12FilingPoly Medicure Limited has informed the Exchange about Investor/Analyst MeetInvestor Call
- 2026-06-10FilingPoly Medicure Limited has informed the Exchange about Investors/Analysts Meet ScheduleInvestor Call
- 2026-01-16BulkSELL Β· βΉ156.3 CrSMALLCAP WORLD FUND INC
- 2025-10-09BlockSELL Β· βΉ50.2 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
- 2025-10-09BlockBUY Β· βΉ50.2 CrGOLDMAN SACHS BANK EUROPE SE - ODI
- 2025-09-18ActionDividend - Rs 3.50 Per ShareDividend
Merged from deals, filings, corporate actions and news β newest first. Scope the deal/action portion with the period chips below.
Filings that matter
- 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF β - 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF β - 3
- 2
3 deals Β· 2025-10-09 β 2026-01-16
| Date | Counterparty | Investor type | Side | Value |
|---|---|---|---|---|
| 2026-01-16 | SMALLCAP WORLD FUND INC | Institution | SELL | βΉ156.3 Cr |
| 2025-10-09 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | HNI / other | SELL | βΉ50.2 Cr |
| 2025-10-09 | GOLDMAN SACHS BANK EUROPE SE - ODI | HNI / other | BUY | βΉ50.2 Cr |
3 deals in the selected window β corporate actions are scoped to the same period. ~2 years of history available.
Results & transcripts
News & chatter on POLYMED
RSS News
0No recent news.
Google News RSS β links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.